{"id":1145,"date":"2023-03-30T19:19:01","date_gmt":"2023-03-30T19:19:01","guid":{"rendered":"https:\/\/diarisanitat.cat\/recerca-en-salut\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/"},"modified":"2024-07-08T15:14:50","modified_gmt":"2024-07-08T15:14:50","slug":"hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19","status":"publish","type":"post","link":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/","title":{"rendered":"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19"},"content":{"rendered":"<p>Una dosi de record de la vacuna de prote\u00efna recombinant bivalent permet una immunitzaci\u00f3 duradora en persones de m\u00e9s de 16 anys. La vacuna ha demostrat ser menys reactog\u00e8nica que les vacunes d\u2019ARNm. \u00c9s la primera vacuna bivalent de prote\u00efna recombinant contra la COVID-19 que s\u2019autoritza a la Uni\u00f3 Europea. L&#8217;estudi ha estat avaluat pel Comit\u00e8 d&#8217;Etica amb Medicaments (CEIm) de l&#8217;hospital Cl\u00ednic Barcelona.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Una dosi de record de la vacuna de prote\u00efna recombinant bivalent permet una immunitzaci\u00f3 duradora en persones de m\u00e9s de 16 anys. La vacuna ha demostrat ser menys reactog\u00e8nica que les vacunes d\u2019ARNm. \u00c9s la primera vacuna bivalent de prote\u00efna recombinant contra la COVID-19 que s\u2019autoritza a la Uni\u00f3 Europea. L&#8217;estudi ha estat avaluat pel<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"tipo":[],"class_list":{"0":"post-1145","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-uncategorized"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19 - Recerca en salut<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19 - Recerca en salut\" \/>\n<meta property=\"og:description\" content=\"Una dosi de record de la vacuna de prote\u00efna recombinant bivalent permet una immunitzaci\u00f3 duradora en persones de m\u00e9s de 16 anys. La vacuna ha demostrat ser menys reactog\u00e8nica que les vacunes d\u2019ARNm. \u00c9s la primera vacuna bivalent de prote\u00efna recombinant contra la COVID-19 que s\u2019autoritza a la Uni\u00f3 Europea. L&#8217;estudi ha estat avaluat pel\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Recerca en salut\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-30T19:19:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-08T15:14:50+00:00\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/\"},\"author\":{\"name\":\"Redacci\u00f3\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9de78768f9e1608c4e3acede8e5f91c4\"},\"headline\":\"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19\",\"datePublished\":\"2023-03-30T19:19:01+00:00\",\"dateModified\":\"2024-07-08T15:14:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/\"},\"wordCount\":92,\"commentCount\":0,\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/\",\"name\":\"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19 - Recerca en salut\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#website\"},\"datePublished\":\"2023-03-30T19:19:01+00:00\",\"dateModified\":\"2024-07-08T15:14:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9de78768f9e1608c4e3acede8e5f91c4\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2023\\\/03\\\/30\\\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#website\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/\",\"name\":\"Recerca en salut\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9de78768f9e1608c4e3acede8e5f91c4\",\"name\":\"Redacci\u00f3\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3\"},\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/author\\\/npenin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19 - Recerca en salut","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/","og_locale":"es_ES","og_type":"article","og_title":"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19 - Recerca en salut","og_description":"Una dosi de record de la vacuna de prote\u00efna recombinant bivalent permet una immunitzaci\u00f3 duradora en persones de m\u00e9s de 16 anys. La vacuna ha demostrat ser menys reactog\u00e8nica que les vacunes d\u2019ARNm. \u00c9s la primera vacuna bivalent de prote\u00efna recombinant contra la COVID-19 que s\u2019autoritza a la Uni\u00f3 Europea. L&#8217;estudi ha estat avaluat pel","og_url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/","og_site_name":"Recerca en salut","article_published_time":"2023-03-30T19:19:01+00:00","article_modified_time":"2024-07-08T15:14:50+00:00","author":"Redacci\u00f3","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Redacci\u00f3"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/#article","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/"},"author":{"name":"Redacci\u00f3","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4"},"headline":"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19","datePublished":"2023-03-30T19:19:01+00:00","dateModified":"2024-07-08T15:14:50+00:00","mainEntityOfPage":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/"},"wordCount":92,"commentCount":0,"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/","name":"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19 - Recerca en salut","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website"},"datePublished":"2023-03-30T19:19:01+00:00","dateModified":"2024-07-08T15:14:50+00:00","author":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4"},"breadcrumb":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2023\/03\/30\/hipra-rep-lopinio-positiva-de-lagencia-europea-del-medicament-per-la-seva-vacuna-contra-la-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/diarisanitat.cat\/recerca-en-salut\/"},{"@type":"ListItem","position":2,"name":"HIPRA rep l\u2019opini\u00f3 positiva de l\u2019Ag\u00e8ncia Europea del Medicament per la seva vacuna contra la COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/","name":"Recerca en salut","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diarisanitat.cat\/recerca-en-salut\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4","name":"Redacci\u00f3","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","caption":"Redacci\u00f3"},"url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/author\/npenin\/"}]}},"_links":{"self":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/1145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/comments?post=1145"}],"version-history":[{"count":1,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/1145\/revisions"}],"predecessor-version":[{"id":37763,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/1145\/revisions\/37763"}],"wp:attachment":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/media?parent=1145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/categories?post=1145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tags?post=1145"},{"taxonomy":"tipo","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tipo?post=1145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}